These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Topical tioconazole versus systemic ketoconazole treatment of vaginal candidiasis. Rohde-Werner H J Int Med Res; 1984; 12(5):298-302. PubMed ID: 6094282 [TBL] [Abstract][Full Text] [Related]
24. Effects of dimethyl sulfoxide (DMSO) on oedema formation in experimental thermal trauma. Arturson G; Pontén B Scand J Plast Reconstr Surg; 1973; 7(1):74-7. PubMed ID: 4752573 [No Abstract] [Full Text] [Related]
25. Cutaneous leishmaniasis in Texas: report of a case and review of the literature. Furner BB J Am Acad Dermatol; 1990 Aug; 23(2 Pt 2):368-71. PubMed ID: 2203832 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis. Saenz RE; Paz H; Berman JD Am J Med; 1990 Aug; 89(2):147-55. PubMed ID: 2166429 [TBL] [Abstract][Full Text] [Related]
27. The effect of percutaneous dimethyl sulfoxide on cutaneous manifestations of systemic sclerosis. Scherbel AL Ann N Y Acad Sci; 1983; 411():120-30. PubMed ID: 6576688 [TBL] [Abstract][Full Text] [Related]
28. [Successful treatment of antimony-resistant cutaneous leishmaniasis]. Kremsner P; Lang I; Kollaritsch H Hautarzt; 1987 Dec; 38(12):733-5. PubMed ID: 2830206 [TBL] [Abstract][Full Text] [Related]
29. Treatment of anthracycline extravasation in mice with dexrazoxane with or without DMSO and hydrocortisone. Langer SW; Thougaard AV; Sehested M; Jensen PB Cancer Chemother Pharmacol; 2006 Jan; 57(1):125-8. PubMed ID: 16001176 [TBL] [Abstract][Full Text] [Related]
30. Soft-tissue injury caused by antineoplastic drugs is inhibited by topical dimethyl sulphoxide and alpha tocopherol. Nobbs P; Barr RD Br J Cancer; 1983 Dec; 48(6):873-6. PubMed ID: 6652029 [No Abstract] [Full Text] [Related]
31. The analgetic action of dimethyl sulfoxide (DMSO) ointment in arthrosis. A double blind study. Vuopala U; Vesterinen E; Kaipainen WJ Acta Rheumatol Scand; 1971; 17(1):57-60. PubMed ID: 4926163 [No Abstract] [Full Text] [Related]
32. Treatment of canine nasal aspergillosis with systemic ketoconazole and topical enilconazole. Sharp NJ; Sullivan M Vet Rec; 1986 May; 118(20):560-1. PubMed ID: 3523960 [No Abstract] [Full Text] [Related]
33. A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey. Ozgoztasi O; Baydar I Int J Dermatol; 1997 Jan; 36(1):61-3. PubMed ID: 9071622 [TBL] [Abstract][Full Text] [Related]
34. Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. Navin TR; Arana BA; Arana FE; Berman JD; Chajón JF J Infect Dis; 1992 Mar; 165(3):528-34. PubMed ID: 1311351 [TBL] [Abstract][Full Text] [Related]
35. Effects of dimethyl sulfoxide on ocular inflammation. Hanna C; Fraunfelder FT; Meyer SM Ann Ophthalmol; 1977 Jan; 9(1):61-5. PubMed ID: 319730 [TBL] [Abstract][Full Text] [Related]
36. The use of DMSO in horses. Mod Vet Pract; 1974 Oct; 55(10):828-9. PubMed ID: 4278343 [No Abstract] [Full Text] [Related]
37. Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis--a practical approach. Parkin J; Shea C; Sant GR Urology; 1997 May; 49(5A Suppl):105-7. PubMed ID: 9146010 [TBL] [Abstract][Full Text] [Related]
38. Lack of ocular changes with dimethyl sulfoxide therapy of scleroderma. Shirley HH; Lundergan MK; Williams HJ; Spruance SL Pharmacotherapy; 1989; 9(3):165-8. PubMed ID: 2755866 [TBL] [Abstract][Full Text] [Related]
39. Failure of ketoconazole treatment in cutaneous leishmaniasis. Singh S; Singh R; Sundar S Int J Dermatol; 1995 Feb; 34(2):120-1. PubMed ID: 7737771 [No Abstract] [Full Text] [Related]
40. [Complex therapy of patients with vertebral radiculopathies]. Zhdanova VM Lik Sprava; 2009; (7-8):62-5. PubMed ID: 20455450 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]